Bone Marrow TransplantationTransplantation ChimeraBone MarrowTransplantation, HomologousBone Marrow CellsChimerismGraft vs Host DiseaseTissue DonorsGraft SurvivalWhole-Body IrradiationTransplantation ConditioningBone and BonesTransplantation ToleranceHematopoietic Stem Cell TransplantationSkin TransplantationHistocompatibility TestingTransplantation, AutologousHematopoietic Stem CellsChimeraHistocompatibilityGraft RejectionAnemia, AplasticLeukemiaHematopoiesisMice, Inbred C57BLImmunosuppressive AgentsLymphocyte DepletionImmunosuppressionRadiation ChimeraBone Marrow DiseasesBone Marrow PurgingTransplantation, IsogeneicGraft Enhancement, ImmunologicBone Marrow ExaminationBone RemodelingImmune ToleranceLiver TransplantationBusulfanLeukocyte TransfusionKidney TransplantationMice, Inbred BALB CBone Marrow NeoplasmsTransplantation ImmunologyRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA AntigensTime FactorsTreatment OutcomeT-LymphocytesCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationBone DensityLiving DonorsActuarial AnalysisBlood DonorsLeukemia, Myeloid, AcuteAcute DiseaseHematologic NeoplasmsCombined Modality TherapySurvival AnalysisColony-Forming Units AssayBone ResorptionLymphocyte Culture Test, MixedRemission InductionLymphocyte TransfusionLeukemia, MyeloidGraft vs Host ReactionCell DifferentiationStem Cell TransplantationCD40 LigandFlow CytometryHepatic Veno-Occlusive DiseaseMyelodysplastic SyndromesLymphoma, Non-HodgkinSevere Combined ImmunodeficiencySpleenBone NeoplasmsCells, CulturedRetrospective StudiesDisease-Free SurvivalHematologic DiseasesMice, Inbred C3HPancytopeniaAntigens, CD34Bone DevelopmentCyclosporineLeukocyte CountGranulocyte Colony-Stimulating FactorMultiple MyelomaGraft vs Tumor EffectBone DiseasesLung TransplantationOrgan TransplantationGranulocytesAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesNuclear FamilyMice, KnockoutSurvival Rate